Omeros Corporation Net Income per Employee (OMER), current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Omeros Corporation  (NASDAQ: OMER)
 

Omeros Net Income per Employee

OMER's Quarterly Results, Trends, Rankings, Statistics
Omeros's Income per employee grew in the second quarter 2026 on a trailing twelve month basis to $ 713,291, the income was higher than average, indicating higher productivity of the company's employees.
The Healthcare sector has seen employees of 30 other companies achieving higher income per employee. While income per employee remained unchanged compared to the previous quarter at no. 336.


What is Income per Employee Ratio?





Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

OMER Net Income per Employee (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Net Income Change - - - - -
Net Income per Employee (TTM) $ 713,291 492,400 -19,143 -692,337 -699,851
OMER's Total Ranking # 336 # 336 # 2451 # 3469 # 3170
Seq. Net Income Change -76.4 % -35.15 % - - -

OMER Company Profile >> Back to OMER Efficiency Comparisons >> Compare OMER Net Income per Employee to its Competitors

OMER Net Income per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 31
Healthcare Sector # 50
Overall Market # 336

Net Income per Employee Statistics
High Average Low
$ 1,138,886 $ -291,787 $ -896,086
(Sep 30 2022)   (Dec 31 2024)







Companies with similar Income per Employee for 12 month ending Jun 30 2026, within Healthcare Sector Income per Employee Income 12 month ending Jun 30 2026Number of Employees Jun 30 2026
Agenus Inc  1,135,037.04 $ 91.938  Million 81 
Tg Therapeutics Inc   1,106,491.23 $ 441.490  Million 399 
Halozyme Therapeutics Inc   977,768.32 $ 413.596  Million 423 
Zevra Therapeutics Inc   949,245.90 $ 57.904  Million 61 
Protagenic Therapeutics Inc new  910,314.00 $ 5.462  Million 6 
Elite Pharmaceuticals Inc   871,814.86 $ 56.668  Million 65 
The Greater Cannabis Company Inc   740,754.00 $ 0.741  Million 1 
Omeros Corporation  713,291.43 $ 124.826  Million 175 
Prestige Consumer Healthcare Inc   712,757.89 $ 406.272  Million 570 
Atlantic Coastal Acquisition Corp Ii  670,333.33 $ 2.011  Million 3 
Illumina Inc   644,531.25 $ 825.000  Million 1,280 
Liquidia Corporation  641,694.44 $ 138.606  Million 216 
Harmony Biosciences Holdings inc   618,668.94 $ 181.270  Million 293 
Theravance Biopharma inc   597,866.67 $ 53.808  Million 90 
Vaxart Inc   593,676.92 $ 38.589  Million 65 
Glucotrack Inc   554,600.00 $ 8.319  Million 15 
Silexion Therapeutics Corp  489,714.29 $ 6.856  Million 14 
Sanuwave Health Inc   488,872.73 $ 26.888  Million 55 
Biolife Solutions Inc   374,070.97 $ 57.981  Million 155 


Date modified: 2026-09-04T00:02:09+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.